상세 보기
Subgroup Analyses of Progression-Free Survival from the Phase 3 Octans and Alcyone Studies in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib, Melphalan, and Prednisone with or without Daratumumab
- Fu, Weijun;
- Bang, Soo-Mee;
- Huang, Honghui;
- Kim, Kihyun;
- Li, Wei;
- ... Lee, Jae Hoon;
- 외 19명
Citations
WEB OF SCIENCE
0- 제목
- Subgroup Analyses of Progression-Free Survival from the Phase 3 Octans and Alcyone Studies in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib, Melphalan, and Prednisone with or without Daratumumab
- 저자
- Fu, Weijun; Bang, Soo-Mee; Huang, Honghui; Kim, Kihyun; Li, Wei; An, Gang; Lee, Je-Jung; Cai, Zhen; Jin, Jie; Wang, Yafei; Chim, Chor Sang; Otero, Paula Rodriguez; Dimopoulos, Meletios A.; Fujisaki, Tomoaki; Lee, Jae Hoon; Wroblewski, Susan; Borgsten, Fredrik; Carson, Robin; Liu, Rui; Zhao, Man; Wu, Tingting; Chen, Xi; Cui, Canchan; Hou, Jian; Wang, Jianxiang
- 발행일
- 2023-11
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 142
- 언어
- ENG
- 출판사
- AMER SOC HEMATOLOGY
- 발행국가
- 미국
- ISSN
- E 1528-0020
P 0006-4971